Terazosin hydrochloride dihydrate (Standard)
Terazosin (hydrochloride dihydrate) (Standard) is the analytical standard of Terazosin (hydrochloride dihydrate). This product is intended for research and analytical applications. Terazosin hydrochloride dihydrate is a quinazoline derivative and a competitive and orally active α1-adrenoceptor antagonist. Terazosin hydrochloride dihydrate works by relaxing blood vessels and the opening of the bladder. Terazosin hydrochloride dihydrate has the potential for benign prostatic hyperplasia (BPH) and high blood pressure treatment.
For research use only. We do not sell to patients.
- Purity: 98%
- CAS No.: 70024-40-7
- Formula: C19H30ClN5O6
- Molecular Weight:459.92
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Purity & Documentation
-
Help & FAQs
-
HY-B0371A
Terazosin hydrochloride dihydrate
-
HY-17498
Atenolol
-
HY-B0203A
Nebivolol hydrochloride
-
HY-B0098A
Doxazosin mesylate
-
HY-B0193A
Prazosin hydrochloride
-
HY-17498R
Atenolol (Standard)
-
HY-17380
(S)-Timolol maleate
-
HY-B0076
Bisoprolol hemifumarate
-
HY-B0381A
Betaxolol hydrochloride
-
HY-17380R
(S)-Timolol maleate (Standard)
-
HY-B0098AR
Doxazosin mesylate (Standard)
-
HY-B0203AR
Nebivolol hydrochloride (Standard)
Product Information
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 70024-40-7
-
Molecular Weight 459.92
-
Formula C19H30ClN5O6
-
SMILES
O=C(N1CCN(C2=NC(N)=C3C=C(OC)C(OC)=CC3=N2)CC1)C4OCCC4.O.Cl.O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Michel MC, et al. Drugs for treatment of benign prostatic hyperplasia: affinity comparison at cloned alpha 1-adrenoceptor subtypes and in human prostate. J Auton Pharmacol. 1996 Feb;16(1):21-8. [Content Brief]
[2]. Vincent J, et al. Pharmacological tolerance to alpha 1-adrenergic receptor antagonism mediated by terazosin in humans. J Clin Invest. 1992 Nov;90(5):1763-8. [Content Brief]
[3]. Ju M, et al. Efficacy of combination terazosin and nifedipine therapy in postoperative treatment of distal ureteral stones after transurethral ureteroscopic lithotripsy. J Int Med Res. 2020 Apr;48(4):300060520904851. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Terazosin hydrochloride dihydrate (Standard) Related Classifications
HY-B0371AR Related Classifications
Powered by Bioz